Tenet Healthcare Corp financial data

Symbol
THC on NYSE
Location
14201 Dallas Parkway, Dallas, TX
State of incorporation
NV
Fiscal year end
December 31
Former names
NATIONAL MEDICAL ENTERPRISES INC /NV/ (to 3/27/1995)
Latest financial report
10-K - Q4 2024 - Feb 18, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 155 % +7.37%
Quick Ratio 7.13 % -23.4%
Debt-to-equity 565 % -64.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 95.1M shares -4.87%
Entity Public Float 9.97B USD +55.8%
Common Stock, Value, Issued 8M USD 0%
Weighted Average Number of Shares Outstanding, Basic 96.9M shares -4.66%
Weighted Average Number of Shares Outstanding, Diluted 97.9M shares -6.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 20.7B USD +0.57%
Operating Income (Loss) 5.96B USD +137%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 5.25B USD +225%
Income Tax Expense (Benefit) 1.18B USD +287%
Earnings Per Share, Basic 33 USD/shares +449%
Earnings Per Share, Diluted 32.7 USD/shares +473%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.02B USD +146%
Accounts Receivable, after Allowance for Credit Loss, Current 2.54B USD -13%
Inventory, Net 346M USD -15.8%
Other Assets, Current 1.76B USD -4.3%
Assets, Current 7.68B USD +7.19%
Deferred Income Tax Assets, Net 80M USD +3.9%
Operating Lease, Right-of-Use Asset 1.04B USD -4.25%
Intangible Assets, Net (Excluding Goodwill) 1.4B USD +2.12%
Goodwill 10.7B USD +3.73%
Assets 28.9B USD +2.2%
Accounts Payable, Current 1.29B USD -8.1%
Employee-related Liabilities, Current 899M USD -3.33%
Contract with Customer, Liability, Current 0 USD
Liabilities, Current 4.31B USD -9.45%
Long-term Debt and Lease Obligation 13.1B USD -12.1%
Deferred Income Tax Liabilities, Net 227M USD -30.4%
Operating Lease, Liability, Noncurrent 950M USD -5.66%
Other Liabilities, Noncurrent 1.57B USD -7.96%
Liabilities 20.4B USD -10.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax -180M USD +0.55%
Retained Earnings (Accumulated Deficit) 3.01B USD
Stockholders' Equity Attributable to Parent 4.17B USD +159%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 5.82B USD +86.7%
Liabilities and Equity 28.9B USD +2.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 586M USD +30.5%
Net Cash Provided by (Used in) Financing Activities -2.66B USD -944%
Net Cash Provided by (Used in) Investing Activities 3.33B USD
Common Stock, Shares Authorized 263M shares 0%
Common Stock, Shares, Issued 158M shares +0.46%
Common Stock, Par or Stated Value Per Share 0.05 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1.25B USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3.02B USD +146%
Interest Paid, Excluding Capitalized Interest, Operating Activities 162M USD -8.48%
Deferred Tax Assets, Valuation Allowance 158M USD -36.3%
Deferred Tax Assets, Gross 1.16B USD -1.11%
Operating Lease, Liability 1.15B USD -4.71%
Payments to Acquire Property, Plant, and Equipment 756M USD -10.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3.2B USD +424%
Lessee, Operating Lease, Liability, to be Paid 1.39B USD -4.98%
Operating Lease, Liability, Current 204M USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Two 230M USD +2.22%
Lessee, Operating Lease, Liability, to be Paid, Year One 261M USD +2.35%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Deferred Income Tax Expense (Benefit) -38M USD -575%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 238M USD -6.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 203M USD +6.84%
Deferred Tax Assets, Operating Loss Carryforwards 122M USD +71.8%
Unrecognized Tax Benefits 73M USD +115%
Lessee, Operating Lease, Liability, to be Paid, Year Four 168M USD +1.82%
Additional Paid in Capital 4.87B USD +0.81%
Amortization of Intangible Assets 45M USD +7.14%
Depreciation, Depletion and Amortization 818M USD -5.98%
Deferred Tax Assets, Net of Valuation Allowance 997M USD +8.37%
Share-based Payment Arrangement, Expense 17M USD +21.4%
Interest Expense 898M USD +1.58%